球部腹侧口腔黏膜补片尿道成形术后标准化排尿试验特征及对无狭窄复发生存的影响
排尿试验成功437例(85.2%),失败76例(14.8%),失败者中54例(71.1%)显示造影剂外渗,22例(28.9%)显示残余狭窄或功能失败。中位随访32个月,排尿试验失败与狭窄复发相关(HR 1.86,p=0.037),其中残余狭窄或功能失败是复发危险因素(HR 4.60,p<0.001),而造影剂外渗无显著关联(HR 1.08,p=0.9)。
要点
- 术后21天排尿试验失败率14.8%,其中残余狭窄或功能失败占28.9%。
- 排尿试验失败与狭窄复发独立相关(HR 1.86,p=0.037)。
- 残余狭窄或功能失败是复发强危险因素(HR 4.60,p<0.001),造影剂外渗无关联。
核心结论
- 口腔黏膜补片尿道成形术后早期排尿试验中残余狭窄或功能失败可预测狭窄复发。
- 排尿试验失败与狭窄复发相关,但仅残余狭窄或功能失败为独立危险因素,造影剂外渗无显著影响。
研究设计与样本
- 术后21天行标准化影像学及功能排尿试验,分为成功与失败组,失败包括影像学失败(造影剂外渗或残余狭窄)和功能失败(排尿后残余尿量大于100 ml)。
主要发现
- 排尿试验成功437例(85.2%),失败76例(14.8%)。
- 失败者中54例(71.1%)显示造影剂外渗,22例(28.9%)显示残余狭窄或功能失败。
- 多因素logistic回归未发现排尿试验失败的术前预测因素(所有p>0.05)。
- 中位随访32个月,Kaplan-Meier分析(log rank检验p=0.033)和多因素Cox回归(HR 1.86,p=0.037)显示排尿试验失败与狭窄复发相关。
- 进一步分层显示,残余狭窄或功能失败是复发危险因素(HR 4.60,p<0.001),而造影剂外渗无显著关联(HR 1.08,p=0.9)。
关键数值与推荐
- 功能失败定义为排尿后残余尿量大于100 ml。
- 影像学失败定义为造影剂外渗或残余狭窄。
- 排尿试验失败与狭窄复发相关(HR 1.86,p=0.037),残余狭窄或功能失败HR 4.60(p<0.001),造影剂外渗HR 1.08(p=0.9)。
临床怎么用
- 术后21天标准化排尿试验可用于识别狭窄复发高风险患者。
- 对于排尿试验显示残余狭窄或功能失败的患者,应加强随访监测。
- 造影剂外渗患者复发风险未见显著增加,可酌情管理。
局限性
- 研究终点的评估为回顾性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to characterize a standardized postoperative radiographic and functional voiding trial, and determine its impact on outcomes after substitution urethroplasty. MATERIALS AND METHODS: This is an observational, monocenter study of men who underwent 1-stage ventral onlay buccal mucosal graft urethroplasty for bulbar urethral stricture between January 2009 and December 2016. Patients were stratified by voiding trial success vs failure, including radiographic (extravasation or residual narrowness) and functional (post-void residual volume greater than 100 ml) failure, 21 days postoperatively. End points were voiding trial failure and recurrence-free survival. Regression models were created to determine risk factors of voiding trial failure and evaluate the impact of voiding trial failure on recurrence. RESULTS: The voiding trial succeeded and failed in 437 (85.2%) and 76 (14.8%), respectively, of 513 men. Of the latter men 54 (71.1%) showed evidence of extravasation and 22 (28.9%) had residual narrowness or functional failure. On multivariable logistic regression analyses no preoperative predictor of voiding trial failure was found (all p >0.05). At a median followup of 32 months Kaplan-Meier analyses (log rank test p = 0.033) and multivariable Cox regression analyses (HR 1.86, p = 0.037) revealed an association of voiding trial failure and stricture recurrence. When further stratifying voiding trial failure, residual narrowness or functional failure (HR 4.60, p <0.001) but not extravasation (HR 1.08, p = 0.9) was a risk factor for recurrence. Limitations include the retrospective assessment of investigated end points. CONCLUSIONS: Residual narrowness or functional failure at an early voiding trial after buccal mucosal graft urethroplasty may predict stricture recurrence. Identifying intraoperative complexity factors predicting initial voiding trial failure might be a key to identifying those individuals with early recurrence.
引用
- Vetterlein MW, Loewe C, Zumstein V, et al. Characterization of a Standardized Postoperative Radiographic and Functional Voiding Trial after 1-Stage Bulbar Ventral Onlay Buccal Mucosal Graft Urethroplasty and the Impact on Stricture Recurrence-Free Survival. J Urol. 2019. PMID: 30240692. doi:10.1016/j.juro.2018.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。